Graham Bigley

Cyclooxygenase-2 Expression in The Barrettʼs Metaplasia–Dysplasia–Adenocarcinoma Sequence

Clive D Morris, Gordon Armstrong, Graham Bigley et al. · The American Journal of Gastroenterology · 2001 · 246 citations

Medicine, Oncology, Pathology +16

First-in-Human Pharmacokinetic and Pharmacodynamic Study of the Dual m-TORC 1/2 Inhibitor AZD2014

Bristi Basu, Emma Dean, M. Puglisi et al. · Clinical Cancer Research · 2015 · 128 citations

Medicine, Oncology, Pharmacology +14

AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules

Sylvie M. Guichard, Jon Curwen, Teeru Bihani et al. · Molecular Cancer Therapeutics · 2015 · 125 citations · Full text

Medicine, Oncology, Pharmacology +17

A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies

Adam Platt, John Morten, Qunsheng Ji et al. · BMC Cancer · 2015 · 59 citations · Full text

Medicine, Genetics, Oncology +17

Dopexamine reduces the incidence of acute inflammation in the gut mucosa after abdominal surgery in high-risk patients

Richard Byers, Jane Eddleston, Robert Pearson et al. · Critical Care Medicine · 1999 · 40 citations

Medicine, Pharmacology, Pharmacotherapy +11